Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014

47th Course of the International School of Crystallography

30 May 2014 - 08 Jun 2014 - Erice, Italy

Bookmark and Share

Diseases, from bacterial and viral infections to cancer to chronic maladies, are still among the greatest problems for mankind, in spite of tremendous progress in genetics, biology, and chemistry.  Approaches to developing new treatments have changed over time, and so have the methodologies used, in order to solve the varied, new, challenging problems that may happen on the path to drug discovery.  Together with ever-evolving experimental techniques, a variety of computational approaches have been applied at the various stages of the drug design process, and in the past two decades structure-based drug design has become one of the mainstream approaches.  This method can be used to target protein-ligand and protein-protein interactions and nowadays is applicable to all aspects of drug discovery, including lead identification, lead optimization, ADMET prediction, and drug repurposing. 

The purpose of the course is dual:

1) It will provide a review of the fundamentals and the application of crystallography to drug design, and an evaluation of the technology at the present state.

2) It will review the progress in this field and summarize the application and results to current fields of interest.  

In addition to lectures, there will be hands-on workshops providing training in using modern computer programs.

The topics that will be covered are:

- Targeting Resistance in Design of Anti AIDS Drugs

- Molecular Modeling and Drug Design

- Targeting Protein-Protein Interactions

- Drug Design Targeting Bromodomains

- Targeting GPCRs for Drug Design

- Targeting Influenza Virus Polymerase

- The Small Molecule Universe

- Molecular Obesity and Other Addictions in Drug Discovery

- Energetics of Protein-Ligand Interactions

- Docking Experiences and Expectations

- Structure of Human G-Protein Coupled Receptor

- Using ARP/WARP for Structure-Based Drug Design

- Antibody Technologies to Stabilize Targets for NCE Screening

- Drug Design Tales from AstraZeneca

- High Resolution Protein-Ligand Interactions by X-rays and Neutrons

- Virus Structure and Antiviral Drug Design

- Structure-Based Design of Drugs Against Diabetes

- Membrane Protein Structure

- Structural Bioinformatics

- Protein Aggregation and Drug Design

- Turning on Enzymes with Small Molecules

Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos